United States · FDA National Drug Code directory
JANUVIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-0221_71d449de-955b-4711-9a44-1e1f66e2e9eb
- Product NDC
- 0006-0221
- Form
- TABLET, FILM COATED
- Composition / generic term
- sitagliptin
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20061016
- Source listing expiry
- 20261231
Source-listed ingredients
- SITAGLIPTIN PHOSPHATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (0006-0221-28) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0006-0221-01) · 0006-0221-28
- 30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31) · 0006-0221-31
- 90 TABLET, FILM COATED in 1 BOTTLE (0006-0221-54) · 0006-0221-54
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →